Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q34185446)
Watch
English
Therapies for sepsis. Emerging therapies for sepsis and septic shock
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
1304118
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9143195%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
title
Therapies for sepsis. Emerging therapies for sepsis and septic shock
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
1304118
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9143195%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
main subject
sepsis
0 references
septic shock
1 reference
based on heuristic
inferred from title
author name string
Abraham E
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
1304118
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9143195%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
language of work or name
English
0 references
publication date
1 March 1997
1 reference
stated in
Europe PubMed Central
PMC publication ID
1304118
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9143195%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
published in
Western Journal of Medicine
1 reference
stated in
Europe PubMed Central
PMC publication ID
1304118
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9143195%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
volume
166
1 reference
stated in
Europe PubMed Central
PMC publication ID
1304118
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9143195%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
issue
3
1 reference
stated in
Europe PubMed Central
PMC publication ID
1304118
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9143195%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
page(s)
195-200
1 reference
stated in
Europe PubMed Central
PMC publication ID
1304118
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9143195%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
cites work
INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1304118
retrieved
5 July 2018
Activity of lipopolysaccharide-binding protein-bactericidal/permeability-increasing protein fusion peptide in an experimental model of Pseudomonas sepsis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1304118
retrieved
5 July 2018
Pathogenetic mechanisms of septic shock
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1304118
retrieved
5 July 2018
Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of gram-negative sepsis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1304118
retrieved
5 July 2018
Influence of IL-1 receptor blockade on the human response to endotoxemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1304118
retrieved
5 July 2018
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1304118
retrieved
5 July 2018
A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1304118
retrieved
5 July 2018
Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1304118
retrieved
5 July 2018
Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1304118
retrieved
5 July 2018
The cardiovascular response of normal humans to the administration of endotoxin.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1304118
retrieved
5 July 2018
Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1304118
retrieved
5 July 2018
Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNF alpha).
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1304118
retrieved
5 July 2018
Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1304118
retrieved
5 July 2018
A specific receptor antagonist for interleukin 1 prevents Escherichia coli ‐induced shock in rabbits
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1304118
retrieved
5 July 2018
Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1304118
retrieved
28 October 2018
Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1304118
retrieved
28 October 2018
Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1304118
retrieved
28 October 2018
Inhibition of nitric oxide synthesis in septic shock: how much is beneficial?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1304118
retrieved
28 October 2018
Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon- , and Interferon- in the Serum of Patients with Septic Shock
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/9143195
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/9143195
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/9143195
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/9143195
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
PMC publication ID
1304118
1 reference
stated in
Europe PubMed Central
PMC publication ID
1304118
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9143195%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
PubMed publication ID
9143195
1 reference
stated in
Europe PubMed Central
PMC publication ID
1304118
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9143195%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
